Viewing Study NCT06673693


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2025-12-26 @ 7:16 PM
Study NCT ID: NCT06673693
Status: RECRUITING
Last Update Posted: 2025-04-16
First Post: 2024-10-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module